187 related articles for article (PubMed ID: 30019166)
1. Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS.
Takeuchi M; Oda S; Tsuneyama K; Yokoi T
Arch Toxicol; 2018 Sep; 92(9):2947-2962. PubMed ID: 30019166
[TBL] [Abstract][Full Text] [Related]
2. miRNA in Rat Liver Sinusoidal Endothelial Cells and Hepatocytes and Application to Circulating Biomarkers that Discern Pathogenesis of Liver Injuries.
Oda S; Takeuchi M; Akai S; Shirai Y; Tsuneyama K; Yokoi T
Am J Pathol; 2018 Apr; 188(4):916-928. PubMed ID: 29353062
[TBL] [Abstract][Full Text] [Related]
3. miR-511-3p promotes hepatic sinusoidal obstruction syndrome by activating hedgehog pathway via targeting Ptch1.
Yang L; Xu X; Chen Z; Zhang Y; Chen H; Wang X
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(3):G344-G354. PubMed ID: 34287088
[TBL] [Abstract][Full Text] [Related]
4. Extravasated platelet aggregation in the livers of rats with drug‑induced hepatic sinusoidal obstruction syndrome.
Hirata M; Tajima H; Miyashita T; Miyata T; Nakanuma S; Makino I; Hayashi H; Oyama K; Takamura H; Ninomiya I; Fushida S; Nakata H; Iseki S; Harada S; Wakayama T; Ohta T
Mol Med Rep; 2017 May; 15(5):3147-3152. PubMed ID: 28358421
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model.
Yamazaki H; Tajima H; Yamamoto Y; Munesue S; Okazaki M; Ohbatake Y; Nakanuma S; Makino I; Miyashita T; Takamura H; Ohta T
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35475446
[TBL] [Abstract][Full Text] [Related]
6. Recovery of Liver Sinusoidal Endothelial Cells Following Monocrotaline-induced Liver Injury.
Otaka F; Ito Y; Goto T; Kojo K; Tanabe M; Hosono K; Majima M; Koizumi W; Amano H
In Vivo; 2021; 35(5):2577-2587. PubMed ID: 34410945
[TBL] [Abstract][Full Text] [Related]
7. Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines.
Li F; Deng Y; Zhang S; Zhu B; Wang J; Wang J; Wang X; Zhao Z; Deng W; Mao R; Shen Z; Chen J; Broering R; Lin Y; Lu M; Zhang J
Emerg Microbes Infect; 2022 Dec; 11(1):616-628. PubMed ID: 35109781
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase III inhibitor attenuates rat sinusoidal obstruction syndrome through inhibition of platelet aggregation in Disse's space.
Miyata T; Tajima H; Hirata M; Nakanuma SI; Makino I; Hayashi H; Oyama K; Miyashita T; Takamura H; Ninomiya I; Fushida S; Iseki S; Harada SI; Wakayama T; Ohta T
J Gastroenterol Hepatol; 2018 Apr; 33(4):950-957. PubMed ID: 28960464
[TBL] [Abstract][Full Text] [Related]
9. Platelets prevent the development of monocrotaline-induced liver injury in mice.
Otaka F; Ito Y; Goto T; Eshima K; Amano H; Koizumi W; Majima M
Toxicol Lett; 2020 Dec; 335():71-81. PubMed ID: 33122006
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a reproducible rat model of hepatic veno-occlusive disease.
DeLeve LD; McCuskey RS; Wang X; Hu L; McCuskey MK; Epstein RB; Kanel GC
Hepatology; 1999 Jun; 29(6):1779-91. PubMed ID: 10347121
[TBL] [Abstract][Full Text] [Related]
11. A metabonomic evaluation of the monocrotaline-induced sinusoidal obstruction syndrome (SOS) in rats.
Conotte R; Colet JM
Toxicol Appl Pharmacol; 2014 Apr; 276(2):147-56. PubMed ID: 24582690
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
[TBL] [Abstract][Full Text] [Related]
13. Liver stiffness and perfusion changes for hepatic sinusoidal obstruction syndrome in rabbit model.
Shin J; Yoon H; Cha YJ; Han K; Lee MJ; Kim MJ; Shin HJ
World J Gastroenterol; 2020 Feb; 26(7):706-716. PubMed ID: 32116418
[TBL] [Abstract][Full Text] [Related]
14. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
[TBL] [Abstract][Full Text] [Related]
15. Melatonin attenuates monocrotaline-induced hepatic sinusoidal obstruction syndrome in rats via activation of Sirtuin-3.
Ren X; Xu K; Xu J; Mei Q
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23422. PubMed ID: 37350538
[TBL] [Abstract][Full Text] [Related]
16. Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.
Takada S; Miyashita T; Yamamoto Y; Kanou S; Munesue S; Ohbatake Y; Nakanuma S; Okamoto K; Sakai S; Kinoshita J; Makino I; Nakamura K; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
In Vivo; 2018; 32(6):1409-1417. PubMed ID: 30348695
[TBL] [Abstract][Full Text] [Related]
17. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic oral sesame oil is ineffectual against monocrotaline-induced sinusoidal obstruction syndrome in rats.
Periasamy S; Chien SP; Liu MY
JPEN J Parenter Enteral Nutr; 2013 Jan; 37(1):129-33. PubMed ID: 22544841
[TBL] [Abstract][Full Text] [Related]
19. Beyond miR-122: Identification of MicroRNA Alterations in Blood During a Time Course of Hepatobiliary Injury and Biliary Hyperplasia in Rats.
Church RJ; Otieno M; McDuffie JE; Singh B; Sonee M; Hall L; Watkins PB; Ellinger-Ziegelbauer H; Harrill AH
Toxicol Sci; 2016 Mar; 150(1):3-14. PubMed ID: 26614776
[TBL] [Abstract][Full Text] [Related]
20. Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome.
Themanns M; Koban F; Bergmayr C; Chrzan A; Strohmaier W; Haybaeck J; Freissmuth M; Zebedin-Brandl E
J Mol Med (Berl); 2019 Feb; 97(2):201-213. PubMed ID: 30535954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
